Neurotech has established several collaborations with world-renowned investigators in ophthalmology at leading research institutes and universities. These collaborations allow Neurotech to access expertise from distinguished scientists and clinicians who are recognized ophthalmic opinion leaders and who can provide valuable feedback regarding scientific research, product design enhancements and clinical trial designs. Neurotech will continue to explore new relationships in order to strengthen our technology and meet unmet patient needs in the field of retinal medicine.

Significant research collaborations include:

Foundation Fighting Blindness
Neurotech has a long-standing relationship with one of the world’s leading charitable organizations dedicated to finding cures for diseases of the eye. The Foundation recognized the potential of Encapsulated Cell Technology (ECT) as an intraocular therapeutic drug delivery technology for retinal diseases and provided critical funding for an initial preclinical proof of principle study.

National Eye Institute (NEI)
The NEI committed substantial resources to early stages of clinical development by assuming investigational responsibility for the initial clinical evaluation of ECT-mediated delivery of Ciliary Neurotrophic Factor (CNTF) in patients with retinitis pigmentosa (Phase 1).

University of Miami/Bascom Palmer Eye Institute
Researchers at Bascom Palmer have provided valuable scientific research as well as clinical development support of ECT, CNTF and follow-on factors under development.

University of Pennsylvania
Researchers at University of Pennsylvania have provided valuable scientific research at the preclinical level in the development of ECT, CNTF and follow-on factors under development.